Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 2156-2160

  Dekkers, Pascale E P ^a   Ten Hove, Tessa ^a   Te Velde, Anje A ^a   Van Deventer, Sander J H ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE RECEPTOR;

ADULT; ARTICLE; ENDOTOXEMIA; ESCHERICHIA COLI; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MONOCYTE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; BLOOD CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; ENZYME PRECURSORS; FLOW CYTOMETRY; HUMANS; INJECTIONS, INTRAVENOUS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; RECEPTORS, CELL SURFACE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034020891     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.2156-2160.2000     Document Type: Article

References (41)

1. Abe, T., Y. Hasegawa, T. Nagasawa, and H. Ninomiya. 1997. Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglohinuria inhibits cell-associated fibrinolytic activity. Int. J. Hematol. 65:285-291.
2. Agosti, J., K. Barbosa, S. M. Coyle, A. Kumar, S. F. Lowry, and T. van der Poll. 1997. Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia. Effect of neutralization of endotoxin-induced TNF activity hy infusion of a recombinant dimeric TNF receptor. J. Immunol. 158:1490-1497.
3. Albrecht, E., T. G. Brock, M. R. Gyetko, S. B. Shollenberger, R. G. Sitrin, R. F. Todd III, and H. R. Petty. 1996. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J. Clin. Investig. 97:1942-1951.
4. Almus-Jacobs, F., D. J. Loskutoff, M. S. Sawday, and N. Varki. 1995. Endotoxin stimulates expression of the murine urokinase receptor gene in vivo. Am. J. Pathol. 147:688-698.
5. Alvarez, P. A., D. A. Brott, D. Y. Liu, and R. F. Todd III. 1985. Bacterial lipopolysaccharide, phorhol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen. Mo3e. J. Immunol. 135:3869-3877.
6. Andreasen, P. A., T. Christensen, J. Gliemann, B. Moller, A. Nykjaer, C. M. Petersen, and R. F. Todd III. 1994. Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol. 152:505-516.
7. Beutler, B., A. Cerami, and I. W. Milsark. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
8. Bianchi, E., F. Fazioli, and E. Ferrero. 1996. Integrin-dependent induction of functional urokinase receptor in primary T lymphocytes. J. Clin. Investig. 98:1133-1141.
9. Blasi, F. 1997. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol. Today 18:415-417.
10. Blohm, D., F. Emling, A. Möller, E. Schlick, and K. Schollmeier. 1990. Monoclonal antibodies to human tumor necrosis factor: in vitro and in vivo application. Cytokine 2:162-169.
11. Bodary, S. C., H. A. Chapman, M. V. Doyle, M. Lukashev, S. Rosenberg, D. I. Simon, and Y. Wei. 1996. Regulation of integrin function by the urokinase receptor. Science 273:1551-1555.
12. Burgal, M., J. Inglés-Esteve, and M. Jardi. 1996. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells. Thromb. Haemostasia 76:1009-1019.
13. Calvano, S. E., A. Kumar, and T. van der Poll. 1995. Endotoxin induces downregulalion of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. Blood 86:2754-2759.
14. Camoglio, L., M. C. M. Tiel-van Buul, and D. Pajkrt. 1997. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia; the effect of timing of rhIL-10 administration. J. Immunol. 158:3971-3977.
15. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101.
16. Carpentier, J. L., A. Estreicher, J. Mülhauser, L. Orci, and J. D. Vassali. 1990. The receptor for urokinase plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111:783-792.
17. Chapman, H. A., R. J. Drummond, N. Rao, S. Rosenberg, D. A. Waltz, and Y. Wei. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
18. Chapman, H. A., L. Kobzik, O. Majdic, N. K. Rao, E. Ronne, D. I. Simon, Y. Wei, and H. Xu. 1996. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 88:3185-3194.
19. Chavakis, T., S. M. Kanse, H. R. Lijnen, K. T. Preissner, and B. Yutzy. 1998. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes. Blood 91:2305-2312.
20. Coyle, S. M., M. Levi, and T. van der Poll. 1997. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89:3727-3734.
21. Dang, J., W. F. Doe, C. J. Jones, X. Liang, J. E. Olsen, and Y. Wang. 1994. Human urokinase receptor protein expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells. FEBS Lett. 353:138-143.
22. Dano, K., J. Eriksen, N. E. Hansen, T. Plesner, and M. Ploug. 1992. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria. Eur. J. Biochem. 208:397-404.
23. DeForge, L. E., M. L. Jones, J. S. Kenney, D. G. Remick, and J. S. Warren. 1992. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J. Immunol. 148:2133-2141.
24. Ellis, V., T. Plesner, and M. Ploug. 1994. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 83:808-815.
25. Faulkner, N. E., M. R. Gyetko, I. F. Mizukami, R. Sitrin, and R. F. Todd III. 1995. Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 86:203-211.
26. Fong, Y., L. L. Moldawer, and K. J. Tracey. 1989. Antibodies to cachectin/ tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1627-1633.
27. Fuller, J. A., M. R. Gyetko, T. J. Standiford, R. G. Sitrin, R. F. Todd III, and H. Petty. 1995. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J. Leukoc. Biol. 58:533-538.
28. Gadd, S. J., W. Kasinrerk, and O. Majdic. 1990. M5, a phosphoinositol-linked human myelomonocytic activation-associated antigen. Clin. Exp. Immunol. 80:252-256.
29. Gisler, R. H., B. A. Imhof, S. M. Kanse, L. R. Lund, A. E. May, and K. T. Preissner. 1998. Urokinase receptor (CD87) regulates leukocyte recruitment via β2 integrins in vivo. J. Exp. Med. 188:1029-1037.
30. Griffiths, J. K., J. W. M. van der Meer, and J. L. Nerad. 1992. Interleukin-1β, IL-1 receptor antagonist, and TNFα production in whole blood. J. Leukoc. Biol. 52:687-692.
31. Gross, T. J., M. R. Gyetko, I. F. Mizukami, R. G. Sitrin, S. B. Sollenberger, and R. F. Todd III. 1994. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood 84:1268-1275.
32. Gyetko, M. R., R. C. Sitrin, R. F. Todd III, and C. C. Wilkinson. 1994. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Investig. 93:1380-1387.
33. Hesse, D. G., Y. Fong, and K. J. Tracey. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
34. Kindzelskii, H. R., A. L. Petty, R. F. Todd III, and W. Xue. 1994. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J. Immunol. 152:4630-4640.
35. Kirchheimer, J. C., Y. H. Nong, and H. G. Remold. 1988 IFN-γ, tumor necrosis factor-α and urokinase regulate the expression of urokinase receptors on human monocytes. J. Immunol. 141:4229-4234.
36. Minnema, M., D. Pajkrt, and P. Stokkers. 1996. Reduction of tumor necrosis factor release by an orally administered metalloproteinase inhibitor (BB 2516) during human endotoxemia, p. 143-150. In D. Pajkrt (ed.), Modulation of inflammatory responses during human endotoxemia. Academic thesis. University of Amsterdam, Amsterdam, The Netherlands. Thesis Publishers, Amsterdam, The Netherlands.
37. Mizukami, I. F., and R. F. Todd III. 1998. A soluble form of the urokinase plasminogen activator receptor (suPAR) can hind to hematopoietic cells. J. Leukoc. Biol. 64:203-213.
38. Nielsen, H. J., A. N. Pedersen, and R. W. Stephens. 1997. ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin. Chem. 43:1868-1876.
39. Pedersen, N., E. Ronne, and M. Schmitt. 1993. A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J. Clin. Investig. 92:2160-2167.
40. van Deventer, S. J. H., D. Pajkrt, and T. van der Poll. 1997. Inflammatory responses during human endotoxemia, p. 14-30. In J. L. Vincent (ed.), Yearbook of intensive care and emergency medicine 1997. Springer-Verlag, New York, N.Y.
41. van Deventer, S. J. H., J. W. ten Cate, J. Jansen, D. Pajkrt, A. Manten, M. M. C. Tiel-van Buul, and T. van der Poll. 1997. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 90:1415-1424.